SUMMARY A population based study of von Recklinghausen neurofibromatosis in south east Wales (population 668 100) identified 69 families with 135 affected members (prevalance 1/4950 of the population). In these families penetrance of the NF-1 gene was 100% by the age of five years. The genetic fitness of NF-1 sufferers was found to be reduced to 0.47, the effect being more marked in males than females (f=0.31 and 0*60, respectively). Forty-one of 135 cases were judged to represent new disease mutations and the mutation rate was estimated to lie between 3.1x10-5 and 10-4x10-5. A parental age effect for new mutations was not found, nor was a maternal effect on disease severity.
The first family in which von Recklinghausen neurofibromatosis (NF-1) occurred in more than one generation was pfobably that reported by Virchowl in 1847. Thomson2 undertook a systematic genetic study in 1900, showing that the disease was familial in 30 of 77 reported cases. Preiser (SMH) . If the diagnosis of NF-I was confirmed, a family study was undertaken and all consenting first degree relatives living within the study area were examined. Relatives of index cases who had died before the study started and whose hospital records indicated a positive family history were contacted through their general practitioner.
The criteria used for diagnosing NF-1 were that an affected subject had two or more of the following: (1) six or more CAL spots measuring more than 1-5 cm in diameter, or more than 0-5 cm in diameter if the patient was 14 years or under; (2) axillary freckling; (3) two or more dermal neurofibromas; (4) a plexiform neurofibroma; (5) 
Results
After exclusions based on insufficient criteria for the diagnosis of NF-1 (seven cases, all personally examined), alternative diagnosis (17 cases, all personally examined), moved from area (1), or difficulty in tracing (1), the diagnosis of NF-1 was accepted in 93 of 119 originally ascertained cases. In 77 of 93 index cases the diagnosis was confirmed by personal examination; six index cases did not wish to be examined but allowed medical and family details to be accessed from their general practitioner/hospital records. The diagnosis was confirmed in all cases. The remaining 10 index cases had died before the study but the diagnosis was accepted on good circumstantial evidence from hospital records; in three out of 10 of these cases one or more first degree relatives had been independently ascertained.
The 93 NF-1 index cases came from 75 families; in six of these, where the index case was dead, no affected relatives living within the study area were identified through hospital records or contact with their general practitioner. Family studies were undertaken on the remaining 69 families, in 13 of which there were two or more index cases. Fifty-two affected relatives (48 personally examined) were ascertained living within the study area.
Therefore a total of 135 subjects (60 males and 75 females) with NF-1 were identified living in the study area (83 index cases and 52 affected relatives). PEDIGREE 
ANALYSIS
The pedigrees confirmed the autosomal dominant inheritance of NF-1. There were numerous examples of male to male transmission and segregation analysis, in families where the index case was an adult and all their offspring had been examined, showed no departure from the expected 1:1 ratio (23/47 children affected).
There were 45 instances of three generation and one of four generation transmission of the disease; in all cases the intervening parent(s) had appropriate manifestations of the disease for their age. The only situation in which difficulty in classification of an at risk subject arose was in young children with between one and five CAL spots and no other features. Four such children (aged six years or under) were identified, classified as being equivocal, and excluded from further analysis.
Forty-one index cases, six affected parents, and one affected grandparent gave no history of NF-1 in their sibs or in preceding generations. Examination of the parents and children of these cases was undertaken wherever possible. The patients were often reluctant to involve their sibs in the study, being adamant that in all cases they were unaffected. Detailed pedigree information is given for these 48 'sporadic' cases in the appendix; there was sufficient information for 41 out of 48 to assume that they represent new mutations of the NF-1 gene. Segregation analysis in the families of the 14 new mutations, where all the children were examined and classified unequivocally, showed no significant departure from the expected 1:1 ratio ( Our analyses of the mutation rate for the NF-1 gene compare with those of previous studies shown in table 1 and confirm that the gene for NF-1 has one of the highest mutation rates yet identified in man. We have been unable to show a significant birth order or parental age effect for new mutations. This was also the case in the study of Samuelsson, 36 who found no parental age (n=25) or birth order (n=28) effect. However, two studies have shown one or both of these effects, both studying larger numbers of patients. Sergeyev7 pooled data from his own and three previous studies to analyse birth order in 193 sibships and, although none of the studies when analysed individually showed a significant birth order, the pooled data did. Sufferers were born later than normal sibs both when whole sibships (p=0004) and sibships without the last sib (p=0-03) were analysed. The 56 cases in Sergeyev's own study also showed weak paternal, but no maternal, age increase over population controls, the paternal age increase being 1-99 years (p=0-03). Riccardi respectively.
In the calculation of Ap, four index cases were excluded since parental InthepopulationestudiedAti165=069;A 0-6;ApA" = 18/65= disease status was uncertain, and in families with more than one index case the 0277; A0' = 12/28=0429; x =60/324 100=0 000185 and xl -75/344 000= parents of the oldest case were used; 29/130 parents had NF-1 (Ap=0-223).
0-000218.
For the estimation of AO, adult index cases where all their children had been examined and the disease status certain were used; 18/38 were affected Therefore: (A0=0-474), therefore:
Relative fitness, w= 022 = 0 470.
0-474
The relative fitness in males (w') and females (w' I) were determined using the formulae25: 
